The Apolipoprotein E ε4 Allele Is Associated with Blunting of Ketamine-Induced Psychosis in Schizophrenia: A Preliminary Report

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Neuropsychopharmacology

• Publication date

  1998-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0893-133X(98)00031-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

  1997cited by this paper
• Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia.

  1997cited by this paper
• Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.

  1997cited by this paper
• Apolipoprotein E ε4 and clinical phenotype in schizophrenia

  1997cited by this paper
• Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics

  1997cited by this paper
• Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region

  1996cited by this paper
• NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

  1996cited by this paper
• Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides

  1996cited by this paper
• Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking

  1996cited by this paper
• The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking.

  1996cited by this paper
• Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking

  1996cited by this paper
• Apolipoprotein E and Alzheimer disease.

  1995cited by this paper
• Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

  1995influential reference
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

  1990cited by this paper
• Aldehyde dehydrogenase polymorphism and alcohol metabolism in alcoholics.

  1985cited by this paper
• The Brief Psychiatric Rating Scale

  1962influential reference

• Ketamine: A Practical Review for the Consultation-Liaison Psychiatrist.

  2023cites this paper
• Association of APOE E2 and low-density lipoprotein with depressive symptoms in Chinese senile schizophrenia inpatients: A cross-sectional study

  2020cites this paper
• Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia

  2020cites this paper
• ApoE elevation is associated with the persistence of psychotic experiences from age 12 to age 18: Evidence from the ALSPAC birth cohort.

  2019cites this paper
• Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers

  2011cites this paper
• Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference

  2011cites this paper
• Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain

  2009cites this paper
• A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia

  2008cites this paper
• Acute and chronic effects of ketamine upon human memory: a review

  2006cites this paper
• Greater vulnerability to the amnestic effects of ketamine in males

  2006influential citation
• Apolipoprotein E genotype and odor identification in schizophrenia.

  2006cites this paper
• Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.

  2003cites this paper
• Ketamina: Nuevas observaciones sobre su consumo, consumidores y efectos

  2003cites this paper
• The neurobiology of apolipoproteins in psychiatric disorders

  2002cites this paper
• A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences

  2000cites this paper